Gerresheimer AG
XETRA:GXI
Gerresheimer AG
XETRA:GXI
Price:
101 EUR
0.6%
Market Closed
Updated:
Apr 30, 2024
Gerresheimer AG
Net Income (Common)
|
Gerresheimer AG
Net Income (Common) Peer Comparison
Comparables:
E
EVT
S
1SXP
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Gerresheimer AG
XETRA:GXI
|
Net Income (Common)
€117.1m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
6%
|
|
E
|
Evotec SE
XETRA:EVT
|
Net Income (Common)
-€95m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-25%
|
|
S
|
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
|
Net Income (Common)
€151.8m
|
CAGR 3-Years
25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Gerresheimer AG's Net Income (Common)?
Net Income (Common)
117.1m
EUR
117.1m
EUR
Based on the financial report for Feb 29, 2024, Gerresheimer AG's Net Income (Common) amounts to 117.1m EUR.
What is Gerresheimer AG's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
6%
6%
Over the last year, the Net Income (Common) growth was 20%. The average annual Net Income (Common) growth rates for Gerresheimer AG have been 8% over the past three years , -8% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
